HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Oncology414 papers

Germ cell neoplasm with hematological malignancy

Last edited: 4/23/2026

Overview

Germ cell neoplasms coexisting with hematological malignancies represent a rare and complex clinical scenario, often requiring multidisciplinary management due to overlapping toxicities and treatment challenges. 1 5 19

Diagnosis

Comprehensive imaging (MRI, CT scans) to identify germ cell tumors and assess hematological malignancy involvement.

Hematological evaluation including bone marrow biopsy and flow cytometry for hematological malignancy confirmation.

Tumor markers specific to germ cell tumors (e.g., AFP, β-HCG) alongside markers for hematological malignancies.

Histopathological examination of tumor tissue for definitive diagnosis. 1 16 31

Management

First-line treatments:

- Chemotherapy regimens tailored for both germ cell tumors and hematological malignancies, such as cisplatin-based regimens for germ cell tumors combined with regimens like R-CHOP for lymphomas. - Targeted therapies specific to the hematological malignancy (e.g., tyrosine kinase inhibitors for CML).

Adjunctive treatments:

- Supportive care including prophylactic antibiotics and antifungal prophylaxis (e.g., fluconazole) to prevent infections, especially in immunocompromised patients. 11 19 21 - Management of extramedullary disease and complications like thrombosis with anticoagulants.

Palliative care integration: Early involvement to manage symptom burden and improve quality of life. 5 77

Special Populations

Pediatrics: Tailored chemotherapy regimens to minimize long-term toxicity, with close monitoring for developmental impacts. 2 25 44

Elderly: Geriatric assessment to guide treatment intensity, focusing on tolerability and quality of life. 77 48

Comorbidities: Careful consideration of cardiovascular risk and thrombotic events, especially in those with pre-existing conditions. 66 6 36

Key Recommendations

Integrate multidisciplinary teams for comprehensive management, including hematologists, oncologists, infectious disease specialists, and palliative care providers. (Evidence: Expert opinion) 1 19

Implement prophylactic antifungal therapy in high-risk patients to prevent CNS infections, particularly in those with prolonged neutropenia. (Evidence: Moderate) 11

Utilize geriatric assessment tools to guide treatment decisions in elderly patients, ensuring personalized care plans. (Evidence: Moderate) 77 48

Incorporate early palliative care to address symptom burden and improve overall quality of life for patients with advanced disease. (Evidence: Strong) 5

References

Showing 100 most recent of 222 indexed papers.

1 Akdas R, Schalk E, Stemler J, Schwartz S, Meyding-Lamadé U, Panse JP et al.. CNS infections in patients with hematological or oncological diseases (including cellular therapies) - 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). European journal of cancer (Oxford, England : 1990) 2026. link 2 Silvestre J. Increasing Rate of Unfilled Training Positions in the Pediatric Hematology Oncology Match. Pediatric blood & cancer 2026. link 3 Borinstein SC, Rose MJ, Moerdler S, Ho R. Personalizing the Pediatric Hematology/Oncology Fellowship: Adapting Training for the Next Generation. Pediatric blood & cancer 2026. link 4 Sohal A, Freedman JL, Aller S, Cobb C, Davis M, Degar B et al.. Hospital-Based Careers in Pediatric Hematology-Oncology: The State of the Field and Future Needs. Pediatric blood & cancer 2026. link 5 Holopainen A, Kuittinen T, Tyynelä-Korhonen K, Lamminmäki A. Symptom burden and palliative care in patients with hematologic malignancies: a single-center experience. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2026. link 6 Lin M, Sun W, Huang X, Zhao X. Disease burden of hematological malignancies worldwide, in China and in the United States based on the GLOBOCAN 2022 and Global Burden of Disease 2021 data. Chinese medical journal 2026. link 7 Madihi S, Bouafi H, Boukaira S, Bennani S, Benani A. Epidemiological trends of hematological malignancies in North Africa: Recent insights. Bulletin du cancer 2026. link 8 Filippatos C, Kanteli I, Pasipoularidou DG, Gavriatopoulou M, Tentolouris A, Malandrakis P et al.. Chimeric Antigen Receptor T-Cells (CAR T-Cells) in Hematological Malignancies: A Systematic Review and Meta-Analysis of Proportions From Clinical Trials. American journal of hematology 2026. link 9 Giordano C, Picardi M, Vincenzi A, Scarpa A, Pane F. Intravascular Complications of Central Venous Catheterization in Chronic Hematological Diseases: Low Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Large Study. Clinical lymphoma, myeloma & leukemia 2026. link 10 Patel VG, Tawagi K, Armstrong SA, Hausrath DJ, Abuali IA, Biswas AN et al.. Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial. JCO oncology practice 2025. link 11 Pagano L, Maschmeyer G, Lamoth F, Blennow O, Xhaard A, Spadea M et al.. Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). Leukemia 2025. link 12 Nakamura S, Maeda Y, Hori T, Oura M. Hematology in community medical care. The journal of medical investigation : JMI 2025. link 13 Abdar Esfahani M, Servatian N, Al-Athari AJH, Khafaja ESM, Rahmani Seraji H, Soleimani Samarkhazan H. The epigenetic revolution in hematology: from benchside breakthroughs to clinical transformations. Clinical and experimental medicine 2025. link 14 Scanlon S, Dzara K, Ronsley R. Current approaches in development and implementation of medical education strategies among pediatric hematology/oncology fellowship programs. Pediatric hematology and oncology 2025. link 15 Nancarrow-Lei R, Durity E, Alfallouji Y, Martyn-Simmons C, Panagou E. The Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital. Journal of drugs in dermatology : JDD 2025. link 16 Hamnvag HM, Van Norman S, Chen Y, Pettit KM, Zhao L, Boyer D et al.. Secondary review of extramural hematopathology cases for patients referred to an academic center: The increasing importance of subspecialized hematopathology practice. American journal of clinical pathology 2025. link 17 Oktay Z, Güner R, Kayaaslan B, Hasanoğlu İ, Kaya Kalem A, Özet G. Investigation of polypharmacy, antimicrobial-related potential drug-drug interactions in patients with hematological malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2025. link 18 Hu R, Shen J, Luo P, Zhang H, He Y. Real-world Hepatobiliary Toxicity After Bispecific T-Cell Engager Therapy: A 10-Year Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System and the World Health Organization's Global Individual Case Safety Report Database. Clinical therapeutics 2025. link 19 Shahid Z, Jain T, Dioverti V, Pennisi M, Mikkilineni L, Thiruvengadam SK et al.. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies. Transplantation and cellular therapy 2024. link 20 Silvestre J, Aakhus E, Weldeslase TA, DeLisser HM. A 15-Year Analysis of Supply and Demand for Hematology and Oncology Training in the United States. JCO oncology practice 2024. link 21 Chen Y, Wang J, Gan X, Li M, Liao Y, Zhou Y et al.. Application of plasma metagenomic next-generation sequencing improves prognosis in hematology patients with neutropenia or hematopoietic stem cell transplantation for infection. Frontiers in cellular and infection microbiology 2024. link 22 Lewis AR, Choong GM, Cathcart-Rake E, Florez N, Durani U, Yadav S et al.. Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat. Journal of cancer education : the official journal of the American Association for Cancer Education 2024. link 23 Walsh K, Manochakian R, Schwartz J, Brondfield S. Launching an International Community of Practice in Hematology/Oncology Medical Education. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2024. link 24 Nixon SM, Maze DC, Parry M, Mayo SJ. Shared-Care in Complex Malignant Hematology: An Integrative Review Using the RE-AIM Evaluation Framework. Current oncology (Toronto, Ont.) 2024. link 25 Russell H, Hord J, Orr CJ, Moerdler S. Child Health and the Pediatric Hematology-Oncology Workforce: 2020-2040. Pediatrics 2024. link 26 Mistry RH, Hausrath DJ, Patel VG. Utility of a Novel Trainee-Level Hematology/Oncology Podcast in Graduate Medical Education: a Pilot Study. Journal of cancer education : the official journal of the American Association for Cancer Education 2024. link 27 Albayrak A, Özbalcı D. Determination of drug-related problems in the hematology service: a prospective interventional study. BMC cancer 2024. link 28 Serey K, Cambriel A, Pollina-Bachellerie A, Bay JO, Bouleuc C, Ladrat L et al.. Hematologists' perspective on advance directives, a French national cross-sectional survey - the ADORE-H study. BMC medical ethics 2024. link 29 Lin SP, Xu XJ, Liao C, Zhao N, Chen YY, Tang YM. Prognostic performance of IL-6 and IL-10 in febrile pediatric hematology/oncology patients with normal procalcitonin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2024. link 30 Falade AS, Hornstein PR, Slater SE, Triedman SA, Buswell LA, Fadelu TA. Survey of Hematology/Oncology Program Leaders on Equity and Global Health Opportunities for Fellows. JCO global oncology 2024. link 31 Bories M, Bannay A, Pierre-Jean M, Bouzille G, Le Corre P. Measurement of Cumulative Drug Exposure from Clinical Data Warehouse. Studies in health technology and informatics 2024. link 32 Alnaeem MM, Shehadeh A, Nashwan AJ. The experience of patients with hematological malignancy in their terminal stage: a phenomenological study from Jordan's perspective. BMC palliative care 2024. link 33 Erdal S, Harman Özdoğan M, Yildirim D, Kuni A, Selçuk S, Güneri A et al.. Effects of Orange Oil Aromatherapy on Pain and Anxiety During Invasive Interventions in Patients With Hematopoietic Stem Cell Transplants. Journal of infusion nursing : the official publication of the Infusion Nurses Society 2024. link 34 Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of hematology 2024. link 35 Turón-Viñas E, López-Torija I, Coca-Fernández E, Badell I, Sierra-Marcos A, Turón M et al.. Seizures in children undergoing stem cell transplantation. Pediatric transplantation 2024. link 36 Yong JH, Mai AS, Matetić A, Elbadawi A, Elgendy IY, Lopez-Fernandez T et al.. Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis. The American journal of cardiology 2024. link 37 Özalp Gerçeker G, Yıldırım BG, Önal A, Ören H, Olgun HN, Bektaş M. The effect of the closed intravenous catheter system on first insertion success, indwelling time, and complications in pediatric hematology and oncology patients: A randomized controlled study. European journal of oncology nursing : the official journal of European Oncology Nursing Society 2023. link 38 Karalexi MA, Kontogeorgi A, Papaioannou G, Neofytou S, Messaropoulos P, Moschovi M et al.. Fertility status in childhood cancer survivors of hematological malignancies: a systematic review. Hormones (Athens, Greece) 2023. link 39 Blijlevens NMA, de Mooij CEM. Mucositis and Infection in Hematology Patients. International journal of molecular sciences 2023. link 40 Găman AM. Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders. International journal of molecular sciences 2023. link 41 Haferlach T, Walter W. Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligence. International journal of laboratory hematology 2023. link 42 Kareff SA, Sridhar A, Dhawan N, Anampa-Guzmán A, Singhi EK, Velazquez AI. The Democratization of Hematology-Oncology Medical Education during the COVID-19 Pandemic. Cancer investigation 2023. link 43 Li X, Zhang P, Sun H, Han L, Jiang Z, Yu J. Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting. Expert opinion on biological therapy 2023. link 44 Bohn MK, Wilson S, Steele S, Adeli K. Comprehensive pediatric reference intervals for 79 hematology markers in the CALIPER cohort of healthy children and adolescents using the Mindray BC-6800Plus system. International journal of laboratory hematology 2023. link 45 Benedetti DJ, Marron JM, Thomas SM, Brown AEC, Pyke-Grimm KA, Johnson LM et al.. The role of ethicists in pediatric hematology/oncology: Current status and future needs. Pediatric blood & cancer 2023. link 46 Rösler W, Altenbuchinger M, Baeßler B, Beissbarth T, Beutel G, Bock R et al.. An overview and a roadmap for artificial intelligence in hematology and oncology. Journal of cancer research and clinical oncology 2023. link 47 de la Rubia J, González B, Cruz-Jentoft AJ, Iglesias L, Jarque I, Persona EP et al.. Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study. Journal of geriatric oncology 2023. link 48 Shivashankara, Banerjee J, Mehrotra R, Wildes TM. Improving care for older adults with hematological malignancies in India: Conquering the challenge. Journal of geriatric oncology 2023. link 49 Pandian SRK, Vijayakumar KK, Kunjiappan S, Babkiewicz E, Maszczyk P. Emerging role of exosomes in hematological malignancies. Clinical and experimental medicine 2023. link 50 Krayem B, Brenner B, Horowitz NA. Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review. Seminars in thrombosis and hemostasis 2023. link 51 Abbasi S, Totmaj MA, Abbasi M, Hajazimian S, Goleij P, Behroozi J et al.. Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies. Cancer medicine 2023. link 52 Báez Gutiérrez N, Rodríguez Ramallo H, Fernández González M, Abdel-Kader Martín L. Smartphone Apps for Patients With Hematologic Malignancies: Systematic Review and Evaluation of Content. JMIR mHealth and uHealth 2022. link 53 Pasqui DM, Latorraca CDOC, Pacheco RL, Riera R. CAR-T cell therapy for patients with hematological malignancies. A systematic review. European journal of haematology 2022. link 54 Takami A. Molecular Immunology in Hematological Disorders. International journal of molecular sciences 2022. link 55 Wang TF, Leader A, Sanfilippo KM. Thrombosis and bleeding in hematological malignancy. Best practice & research. Clinical haematology 2022. link 56 Zini G, Barbagallo O, Scavone F, Béné MC. Digital morphology in hematology diagnosis and education: The experience of the European LeukemiaNet WP10. International journal of laboratory hematology 2022. link 57 Kallel F, Masmoudi S, Kassar O, Mallek R, Medhaffar M, Elloumi M. Prospective observational study of palliative care in hematological malignancies: Report of one year of practice. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2022. link 58 Syaj S, Al-Kraimeen L, Akhdar M, Abushukair H, Mohty R, Al Hadidi S. Gender and early-career faculty disparities in hematology and oncology board review lecture series. Blood advances 2022. link 59 Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nabéra C et al.. The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia 2022. link 60 Muthiah A, Aggarwal V, Muthiah C, Wei C, Ollila T, Quesenberry MI et al.. Analysis of Hematology and Oncology Fellowship Website Content and Diversity Representation. JCO oncology practice 2022. link 61 Velazquez AI, Durani U, Weeks LD, Major A, Reynolds R, Kumbamu A et al.. Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors. JCO oncology practice 2022. link 62 Piñana JL, Vázquez L, Martino R, de la Cámara R, Sureda A, Rodríguez-Veiga R et al.. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. Leukemia & lymphoma 2022. link 63 Haggenburg S, Lissenberg-Witte BI, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE et al.. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients. Blood advances 2022. link 64 Tomasik J, Jasiński M, Basak GW. Next generations of CAR-T cells - new therapeutic opportunities in hematology?. Frontiers in immunology 2022. link 65 Gavriatopoulou M, Terpos E, Kastritis E, Briasoulis A, Gumeni S, Ntanasis-Stathopoulos I et al.. Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine. Clinical and experimental medicine 2022. link 66 Peixoto da Silva S, Caires HR, Bergantim R, Guimarães JE, Vasconcelos MH. miRNAs mediated drug resistance in hematological malignancies. Seminars in cancer biology 2022. link 67 Hsin J, Mitchell J, Thompson J, Kaneshiro C, Troncoso A. Tubing determination in an hematology oncology clinic. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2021. link 68 Gonzalez F, Beschmout S, Chow-Chine L, Bisbal M, d'Incan E, Servan L et al.. Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome. Journal of critical care 2021. link 69 Benning TJ, Shah ND, Inselman JW, Van Houten HK, Ross JS, Wyatt KD. Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation. Clinical trials (London, England) 2021. link 70 Diaz MA, Gasior M, Molina B, Pérez-Martínez A, González-Vicent M. "Ex-vivo" T-cell depletion in allogeneic hematopoietic stem cell transplantation: New clinical approaches for old challenges. European journal of haematology 2021. link 71 Kohyama K, Kiyota M, Inoshima Y. Longitudinal study of northern fur seal (Callorhinus ursinus) hematology. The Journal of veterinary medical science 2021. link 72 Yu JS, Louer R, Lutfi R, Abu-Sultaneh S, Yabrodi M, Zee-Cheng J et al.. Adjuvant lidocaine to a propofol-ketamine-based sedation regimen for bone marrow aspirates and biopsy in the pediatric population. European journal of pediatrics 2021. link 73 Pavlovic M, Dordevic A, Haßfeld S, Cuspidi C, Düngen HD, Tadic M. Left ventricular mechanics in patients with hematological malignancies before initiation of chemo- and radiotherapy. The international journal of cardiovascular imaging 2021. link 74 Surov A, Wienke A. Sarcopenia predicts overall survival in patients with malignant hematological diseases: A meta-analysis. Clinical nutrition (Edinburgh, Scotland) 2021. link 75 Lodish HF. Over 60 Years of Experimental Hematology (without a License). Experimental hematology 2020. link 76 Rello J, Sarda C, Mokart D, Arvaniti K, Akova M, Tabah A et al.. Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2020. link 77 Gregory GP, Carrington C, Cheah CY, Hawkes EA, Irving IM, Siderov J et al.. A consensus statement on the use of biosimilar medicines in hematology in Australia. Asia-Pacific journal of clinical oncology 2020. link 78 Gudiol C, Aguilar-Guisado M, Azanza JR, Candel FJ, Cantón R, Carratalà J et al.. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies. Enfermedades infecciosas y microbiologia clinica (English ed.) 2020. link 79 Tien KL, Sheng WH, Shieh SC, Hung YP, Tien HF, Chen YH et al.. Chlorhexidine Bathing to Prevent Central Line-Associated Bloodstream Infections in Hematology Units: A Prospective, Controlled Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. link 80 Olmuşçelik O, Sevindik ÖG. Correlation between serum vitamin D level and dichotomous distribution of hematological parameters in a cohort of 12709 patients. Turkish journal of medical sciences 2020. link 81 Bakalov V, Tang A, Yellala A, Kaplan R, Lister J, Sadashiv S. Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the National Inpatient Sample, 2011-2015. Leukemia & lymphoma 2020. link 82 Winsnes K, Sochacki P, Eriksson C, Shereck E, Recht M, Johnson K et al.. Delirium in the pediatric hematology, oncology, and bone marrow transplant population. Pediatric blood & cancer 2019. link 83 Duregon F, Gobbo S, Bullo V, Roma E, Vendramin B, Bergamo M et al.. Exercise prescription and tailored physical activity intervention in onco-hematology inpatients, a personalized bedside approach to improve clinical best practice. Hematological oncology 2019. link 84 Zizioli D, Mione M, Varinelli M, Malagola M, Bernardi S, Alghisi E et al.. Zebrafish disease models in hematology: Highlights on biological and translational impact. Biochimica et biophysica acta. Molecular basis of disease 2019. link 85 Yumura Y, Tsujimura A, Okada H, Ota K, Kitazawa M, Suzuki T et al.. Recognition and attitudes of Japanese hematologists on sperm banking before chemotherapy: present status from nationwide questionnaire survey. International journal of clinical oncology 2019. link 86 Soma LA, Kovach AE, Siddon AJ, Beck R, Gibson SE, Swerdlow SH et al.. Molecular and Cytogenetic Education in Hematopathology Fellowship. American journal of clinical pathology 2019. link 87 Makhoul I, Motwani P, Schafer L, Arnaoutakis K, Mahmoud F, Safar M et al.. Integrating Collaborative Learning and Competition in a Hematology/Oncology Training Program. Journal of cancer education : the official journal of the American Association for Cancer Education 2018. link 88 Collichio F, Muchmore EA. The American Society of Hematology and ASCO Curricular Milestones for Assessment of Fellows in Hematology/Oncology: Development, Reflection, and Next Steps. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018. link 89 Oliveira LR, Simionatto M, Cruz BR, Bittencourt JIM, Krum EA, Moss MF et al.. Stability of complete blood count in different storage conditions using the ABX PENTRA 60 analyzer. International journal of laboratory hematology 2018. link 90 Horikoshi Y, Kaneko T, Morikawa Y, Isogai M, Suwa J, Higuchi H et al.. The North Wind and the Sun: Pediatric Antimicrobial Stewardship Program Combining Restrictive and Persuasive Approaches in Hematology-Oncology Ward and Hematopoietic Stem Cell Transplant Unit. The Pediatric infectious disease journal 2018. link 91 Ball S, Nugent K. Microparticles in Hematological Malignancies: Role in Coagulopathy and Tumor Pathogenesis. The American journal of the medical sciences 2018. link 92 Abuhadra N, Majhail NS, Nazha A. Impact of social media for the hematologist/oncologist. Seminars in hematology 2017. link 93 Elemary M, Seghatchian J, Stakiw J, Bosch M, Sabry W, Goubran H. Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - Literature review and local experience. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2017. link 94 Svensson T, Lundström KL, Höglund M, Cherif H. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?. Upsala journal of medical sciences 2017. link 95 McGrath P. Financial Assistance for Patients Who Relocate for Specialist Care in Hematology: Practical Findings to Inform Nursing Supportive Care. Nursing forum 2017. link 96 Wayant C, Scheckel C, Hicks C, Nissen T, Leduc L, Som M et al.. Evidence of selective reporting bias in hematology journals: A systematic review. PloS one 2017. link 97 Attai DJ, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim J et al.. Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine. Seminars in hematology 2017. link 98 Petit M, Mine L, Pascreau T, Brouzes C, Majoux S, Borgel D et al.. Preanalytical influence of pneumatic tube delivery system on results of routine biochemistry and haematology analysis. Annales de biologie clinique 2017. link 99 Crysandt M, Yakoub-Agha I, Reiß P, Theisen S, Silling G, Glatte P et al.. How to build an allogeneic hematopoietic cell transplant unit in 2016: Proposal for a practical framework. Current research in translational medicine 2017. link 100 Collichio FA, Hess BJ, Muchmore EA, Duhigg L, Lipner RS, Haist S et al.. Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance. Journal of cancer education : the official journal of the American Association for Cancer Education 2017. link

Original source

[1]
CNS infections in patients with hematological or oncological diseases (including cellular therapies) - 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). — Akdas R, Schalk E, Stemler J, Schwartz S, Meyding-Lamadé U, Panse JP et al. European journal of cancer (Oxford, England : 1990) (2026)
[2]
Increasing Rate of Unfilled Training Positions in the Pediatric Hematology Oncology Match. — Silvestre J Pediatric blood & cancer (2026)
[3]
Personalizing the Pediatric Hematology/Oncology Fellowship: Adapting Training for the Next Generation. — Borinstein SC, Rose MJ, Moerdler S, Ho R Pediatric blood & cancer (2026)
[4]
Hospital-Based Careers in Pediatric Hematology-Oncology: The State of the Field and Future Needs. — Sohal A, Freedman JL, Aller S, Cobb C, Davis M, Degar B et al. Pediatric blood & cancer (2026)
[5]
Symptom burden and palliative care in patients with hematologic malignancies: a single-center experience. — Holopainen A, Kuittinen T, Tyynelä-Korhonen K, Lamminmäki A Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2026)
[6]
Disease burden of hematological malignancies worldwide, in China and in the United States based on the GLOBOCAN 2022 and Global Burden of Disease 2021 data. — Lin M, Sun W, Huang X, Zhao X Chinese medical journal (2026)
[7]
Epidemiological trends of hematological malignancies in North Africa: Recent insights. — Madihi S, Bouafi H, Boukaira S, Bennani S, Benani A Bulletin du cancer (2026)
[8]
Chimeric Antigen Receptor T-Cells (CAR T-Cells) in Hematological Malignancies: A Systematic Review and Meta-Analysis of Proportions From Clinical Trials. — Filippatos C, Kanteli I, Pasipoularidou DG, Gavriatopoulou M, Tentolouris A, Malandrakis P et al. American journal of hematology (2026)
[9]
Intravascular Complications of Central Venous Catheterization in Chronic Hematological Diseases: Low Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Large Study. — Giordano C, Picardi M, Vincenzi A, Scarpa A, Pane F Clinical lymphoma, myeloma & leukemia (2026)
[10]
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial. — Patel VG, Tawagi K, Armstrong SA, Hausrath DJ, Abuali IA, Biswas AN et al. JCO oncology practice (2025)
[11]
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). — Pagano L, Maschmeyer G, Lamoth F, Blennow O, Xhaard A, Spadea M et al. Leukemia (2025)
[12]
Hematology in community medical care. — Nakamura S, Maeda Y, Hori T, Oura M The journal of medical investigation : JMI (2025)
[13]
The epigenetic revolution in hematology: from benchside breakthroughs to clinical transformations. — Abdar Esfahani M, Servatian N, Al-Athari AJH, Khafaja ESM, Rahmani Seraji H, Soleimani Samarkhazan H Clinical and experimental medicine (2025)
[14]
Current approaches in development and implementation of medical education strategies among pediatric hematology/oncology fellowship programs. — Scanlon S, Dzara K, Ronsley R Pediatric hematology and oncology (2025)
[15]
The Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital. — Nancarrow-Lei R, Durity E, Alfallouji Y, Martyn-Simmons C, Panagou E Journal of drugs in dermatology : JDD (2025)
[16]
Secondary review of extramural hematopathology cases for patients referred to an academic center: The increasing importance of subspecialized hematopathology practice. — Hamnvag HM, Van Norman S, Chen Y, Pettit KM, Zhao L, Boyer D et al. American journal of clinical pathology (2025)
[17]
Investigation of polypharmacy, antimicrobial-related potential drug-drug interactions in patients with hematological malignancies. — Oktay Z, Güner R, Kayaaslan B, Hasanoğlu İ, Kaya Kalem A, Özet G Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2025)
[18]
Real-world Hepatobiliary Toxicity After Bispecific T-Cell Engager Therapy: A 10-Year Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System and the World Health Organization's Global Individual Case Safety Report Database. — Hu R, Shen J, Luo P, Zhang H, He Y Clinical therapeutics (2025)
[19]
Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies. — Shahid Z, Jain T, Dioverti V, Pennisi M, Mikkilineni L, Thiruvengadam SK et al. Transplantation and cellular therapy (2024)
[20]
A 15-Year Analysis of Supply and Demand for Hematology and Oncology Training in the United States. — Silvestre J, Aakhus E, Weldeslase TA, DeLisser HM JCO oncology practice (2024)
[21]
Application of plasma metagenomic next-generation sequencing improves prognosis in hematology patients with neutropenia or hematopoietic stem cell transplantation for infection. — Chen Y, Wang J, Gan X, Li M, Liao Y, Zhou Y et al. Frontiers in cellular and infection microbiology (2024)
[22]
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat. — Lewis AR, Choong GM, Cathcart-Rake E, Florez N, Durani U, Yadav S et al. Journal of cancer education : the official journal of the American Association for Cancer Education (2024)
[23]
Launching an International Community of Practice in Hematology/Oncology Medical Education. — Walsh K, Manochakian R, Schwartz J, Brondfield S American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting (2024)
[24]
Shared-Care in Complex Malignant Hematology: An Integrative Review Using the RE-AIM Evaluation Framework. — Nixon SM, Maze DC, Parry M, Mayo SJ Current oncology (Toronto, Ont.) (2024)
[25]
Child Health and the Pediatric Hematology-Oncology Workforce: 2020-2040. — Russell H, Hord J, Orr CJ, Moerdler S Pediatrics (2024)
[26]
Utility of a Novel Trainee-Level Hematology/Oncology Podcast in Graduate Medical Education: a Pilot Study. — Mistry RH, Hausrath DJ, Patel VG Journal of cancer education : the official journal of the American Association for Cancer Education (2024)
[27]
Determination of drug-related problems in the hematology service: a prospective interventional study. — Albayrak A, Özbalcı D BMC cancer (2024)
[28]
Hematologists' perspective on advance directives, a French national cross-sectional survey - the ADORE-H study. — Serey K, Cambriel A, Pollina-Bachellerie A, Bay JO, Bouleuc C, Ladrat L et al. BMC medical ethics (2024)
[29]
Prognostic performance of IL-6 and IL-10 in febrile pediatric hematology/oncology patients with normal procalcitonin. — Lin SP, Xu XJ, Liao C, Zhao N, Chen YY, Tang YM Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (2024)
[30]
Survey of Hematology/Oncology Program Leaders on Equity and Global Health Opportunities for Fellows. — Falade AS, Hornstein PR, Slater SE, Triedman SA, Buswell LA, Fadelu TA JCO global oncology (2024)
[31]
Measurement of Cumulative Drug Exposure from Clinical Data Warehouse. — Bories M, Bannay A, Pierre-Jean M, Bouzille G, Le Corre P Studies in health technology and informatics (2024)
[32]
The experience of patients with hematological malignancy in their terminal stage: a phenomenological study from Jordan's perspective. — Alnaeem MM, Shehadeh A, Nashwan AJ BMC palliative care (2024)
[33]
Effects of Orange Oil Aromatherapy on Pain and Anxiety During Invasive Interventions in Patients With Hematopoietic Stem Cell Transplants. — Erdal S, Harman Özdoğan M, Yildirim D, Kuni A, Selçuk S, Güneri A et al. Journal of infusion nursing : the official publication of the Infusion Nurses Society (2024)
[34]
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. — Li W, Fu Y, Wang W Annals of hematology (2024)
[35]
Seizures in children undergoing stem cell transplantation. — Turón-Viñas E, López-Torija I, Coca-Fernández E, Badell I, Sierra-Marcos A, Turón M et al. Pediatric transplantation (2024)
[36]
Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis. — Yong JH, Mai AS, Matetić A, Elbadawi A, Elgendy IY, Lopez-Fernandez T et al. The American journal of cardiology (2024)
[37]
The effect of the closed intravenous catheter system on first insertion success, indwelling time, and complications in pediatric hematology and oncology patients: A randomized controlled study. — Özalp Gerçeker G, Yıldırım BG, Önal A, Ören H, Olgun HN, Bektaş M European journal of oncology nursing : the official journal of European Oncology Nursing Society (2023)
[38]
Fertility status in childhood cancer survivors of hematological malignancies: a systematic review. — Karalexi MA, Kontogeorgi A, Papaioannou G, Neofytou S, Messaropoulos P, Moschovi M et al. Hormones (Athens, Greece) (2023)
[39]
Mucositis and Infection in Hematology Patients. — Blijlevens NMA, de Mooij CEM International journal of molecular sciences (2023)
[40]
Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders. — Găman AM International journal of molecular sciences (2023)
[41]
Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligence. — Haferlach T, Walter W International journal of laboratory hematology (2023)
[42]
The Democratization of Hematology-Oncology Medical Education during the COVID-19 Pandemic. — Kareff SA, Sridhar A, Dhawan N, Anampa-Guzmán A, Singhi EK, Velazquez AI Cancer investigation (2023)
[43]
Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting. — Li X, Zhang P, Sun H, Han L, Jiang Z, Yu J Expert opinion on biological therapy (2023)
[44]
Comprehensive pediatric reference intervals for 79 hematology markers in the CALIPER cohort of healthy children and adolescents using the Mindray BC-6800Plus system. — Bohn MK, Wilson S, Steele S, Adeli K International journal of laboratory hematology (2023)
[45]
The role of ethicists in pediatric hematology/oncology: Current status and future needs. — Benedetti DJ, Marron JM, Thomas SM, Brown AEC, Pyke-Grimm KA, Johnson LM et al. Pediatric blood & cancer (2023)
[46]
An overview and a roadmap for artificial intelligence in hematology and oncology. — Rösler W, Altenbuchinger M, Baeßler B, Beissbarth T, Beutel G, Bock R et al. Journal of cancer research and clinical oncology (2023)
[47]
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study. — de la Rubia J, González B, Cruz-Jentoft AJ, Iglesias L, Jarque I, Persona EP et al. Journal of geriatric oncology (2023)
[48]
Improving care for older adults with hematological malignancies in India: Conquering the challenge. — Shivashankara, Banerjee J, Mehrotra R, Wildes TM Journal of geriatric oncology (2023)
[49]
Emerging role of exosomes in hematological malignancies. — Pandian SRK, Vijayakumar KK, Kunjiappan S, Babkiewicz E, Maszczyk P Clinical and experimental medicine (2023)
[50]
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review. — Krayem B, Brenner B, Horowitz NA Seminars in thrombosis and hemostasis (2023)
[51]
Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies. — Abbasi S, Totmaj MA, Abbasi M, Hajazimian S, Goleij P, Behroozi J et al. Cancer medicine (2023)
[52]
Smartphone Apps for Patients With Hematologic Malignancies: Systematic Review and Evaluation of Content. — Báez Gutiérrez N, Rodríguez Ramallo H, Fernández González M, Abdel-Kader Martín L JMIR mHealth and uHealth (2022)
[53]
CAR-T cell therapy for patients with hematological malignancies. A systematic review. — Pasqui DM, Latorraca CDOC, Pacheco RL, Riera R European journal of haematology (2022)
[54]
Molecular Immunology in Hematological Disorders. — Takami A International journal of molecular sciences (2022)
[55]
Thrombosis and bleeding in hematological malignancy. — Wang TF, Leader A, Sanfilippo KM Best practice & research. Clinical haematology (2022)
[56]
Digital morphology in hematology diagnosis and education: The experience of the European LeukemiaNet WP10. — Zini G, Barbagallo O, Scavone F, Béné MC International journal of laboratory hematology (2022)
[57]
Prospective observational study of palliative care in hematological malignancies: Report of one year of practice. — Kallel F, Masmoudi S, Kassar O, Mallek R, Medhaffar M, Elloumi M Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine (2022)
[58]
Gender and early-career faculty disparities in hematology and oncology board review lecture series. — Syaj S, Al-Kraimeen L, Akhdar M, Abushukair H, Mohty R, Al Hadidi S Blood advances (2022)
[59]
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH). — Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nabéra C et al. Leukemia (2022)
[60]
Analysis of Hematology and Oncology Fellowship Website Content and Diversity Representation. — Muthiah A, Aggarwal V, Muthiah C, Wei C, Ollila T, Quesenberry MI et al. JCO oncology practice (2022)
[61]
Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors. — Velazquez AI, Durani U, Weeks LD, Major A, Reynolds R, Kumbamu A et al. JCO oncology practice (2022)
[62]
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. — Piñana JL, Vázquez L, Martino R, de la Cámara R, Sureda A, Rodríguez-Veiga R et al. Leukemia & lymphoma (2022)
[63]
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients. — Haggenburg S, Lissenberg-Witte BI, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE et al. Blood advances (2022)
[64]
Next generations of CAR-T cells - new therapeutic opportunities in hematology? — Tomasik J, Jasiński M, Basak GW Frontiers in immunology (2022)
[65]
Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine. — Gavriatopoulou M, Terpos E, Kastritis E, Briasoulis A, Gumeni S, Ntanasis-Stathopoulos I et al. Clinical and experimental medicine (2022)
[66]
miRNAs mediated drug resistance in hematological malignancies. — Peixoto da Silva S, Caires HR, Bergantim R, Guimarães JE, Vasconcelos MH Seminars in cancer biology (2022)
[67]
Tubing determination in an hematology oncology clinic. — Hsin J, Mitchell J, Thompson J, Kaneshiro C, Troncoso A Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
[68]
Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome. — Gonzalez F, Beschmout S, Chow-Chine L, Bisbal M, d'Incan E, Servan L et al. Journal of critical care (2021)
[69]
Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation. — Benning TJ, Shah ND, Inselman JW, Van Houten HK, Ross JS, Wyatt KD Clinical trials (London, England) (2021)
[70]
"Ex-vivo" T-cell depletion in allogeneic hematopoietic stem cell transplantation: New clinical approaches for old challenges. — Diaz MA, Gasior M, Molina B, Pérez-Martínez A, González-Vicent M European journal of haematology (2021)
[71]
Longitudinal study of northern fur seal (Callorhinus ursinus) hematology. — Kohyama K, Kiyota M, Inoshima Y The Journal of veterinary medical science (2021)
[72]
Adjuvant lidocaine to a propofol-ketamine-based sedation regimen for bone marrow aspirates and biopsy in the pediatric population. — Yu JS, Louer R, Lutfi R, Abu-Sultaneh S, Yabrodi M, Zee-Cheng J et al. European journal of pediatrics (2021)
[73]
Left ventricular mechanics in patients with hematological malignancies before initiation of chemo- and radiotherapy. — Pavlovic M, Dordevic A, Haßfeld S, Cuspidi C, Düngen HD, Tadic M The international journal of cardiovascular imaging (2021)
[74]
Sarcopenia predicts overall survival in patients with malignant hematological diseases: A meta-analysis. — Surov A, Wienke A Clinical nutrition (Edinburgh, Scotland) (2021)
[75]
Over 60 Years of Experimental Hematology (without a License). — Lodish HF Experimental hematology (2020)
[76]
Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network. — Rello J, Sarda C, Mokart D, Arvaniti K, Akova M, Tabah A et al. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2020)
[77]
A consensus statement on the use of biosimilar medicines in hematology in Australia. — Gregory GP, Carrington C, Cheah CY, Hawkes EA, Irving IM, Siderov J et al. Asia-Pacific journal of clinical oncology (2020)
[78]
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies. — Gudiol C, Aguilar-Guisado M, Azanza JR, Candel FJ, Cantón R, Carratalà J et al. Enfermedades infecciosas y microbiologia clinica (English ed.) (2020)
[79]
Chlorhexidine Bathing to Prevent Central Line-Associated Bloodstream Infections in Hematology Units: A Prospective, Controlled Cohort Study. — Tien KL, Sheng WH, Shieh SC, Hung YP, Tien HF, Chen YH et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2020)
[80]
Correlation between serum vitamin D level and dichotomous distribution of hematological parameters in a cohort of 12709 patients. — Olmuşçelik O, Sevindik ÖG Turkish journal of medical sciences (2020)
[81]
Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the National Inpatient Sample, 2011-2015. — Bakalov V, Tang A, Yellala A, Kaplan R, Lister J, Sadashiv S Leukemia & lymphoma (2020)
[82]
Delirium in the pediatric hematology, oncology, and bone marrow transplant population. — Winsnes K, Sochacki P, Eriksson C, Shereck E, Recht M, Johnson K et al. Pediatric blood & cancer (2019)
[83]
Exercise prescription and tailored physical activity intervention in onco-hematology inpatients, a personalized bedside approach to improve clinical best practice. — Duregon F, Gobbo S, Bullo V, Roma E, Vendramin B, Bergamo M et al. Hematological oncology (2019)
[84]
Zebrafish disease models in hematology: Highlights on biological and translational impact. — Zizioli D, Mione M, Varinelli M, Malagola M, Bernardi S, Alghisi E et al. Biochimica et biophysica acta. Molecular basis of disease (2019)
[85]
Recognition and attitudes of Japanese hematologists on sperm banking before chemotherapy: present status from nationwide questionnaire survey. — Yumura Y, Tsujimura A, Okada H, Ota K, Kitazawa M, Suzuki T et al. International journal of clinical oncology (2019)
[86]
Molecular and Cytogenetic Education in Hematopathology Fellowship. — Soma LA, Kovach AE, Siddon AJ, Beck R, Gibson SE, Swerdlow SH et al. American journal of clinical pathology (2019)
[87]
Integrating Collaborative Learning and Competition in a Hematology/Oncology Training Program. — Makhoul I, Motwani P, Schafer L, Arnaoutakis K, Mahmoud F, Safar M et al. Journal of cancer education : the official journal of the American Association for Cancer Education (2018)
[88]
The American Society of Hematology and ASCO Curricular Milestones for Assessment of Fellows in Hematology/Oncology: Development, Reflection, and Next Steps. — Collichio F, Muchmore EA American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting (2018)
[89]
Stability of complete blood count in different storage conditions using the ABX PENTRA 60 analyzer. — Oliveira LR, Simionatto M, Cruz BR, Bittencourt JIM, Krum EA, Moss MF et al. International journal of laboratory hematology (2018)
[90]
The North Wind and the Sun: Pediatric Antimicrobial Stewardship Program Combining Restrictive and Persuasive Approaches in Hematology-Oncology Ward and Hematopoietic Stem Cell Transplant Unit. — Horikoshi Y, Kaneko T, Morikawa Y, Isogai M, Suwa J, Higuchi H et al. The Pediatric infectious disease journal (2018)
[91]
Microparticles in Hematological Malignancies: Role in Coagulopathy and Tumor Pathogenesis. — Ball S, Nugent K The American journal of the medical sciences (2018)
[92]
Impact of social media for the hematologist/oncologist. — Abuhadra N, Majhail NS, Nazha A Seminars in hematology (2017)
[93]
Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - Literature review and local experience. — Elemary M, Seghatchian J, Stakiw J, Bosch M, Sabry W, Goubran H Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis (2017)
[94]
Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed? — Svensson T, Lundström KL, Höglund M, Cherif H Upsala journal of medical sciences (2017)
[95]
Financial Assistance for Patients Who Relocate for Specialist Care in Hematology: Practical Findings to Inform Nursing Supportive Care. — McGrath P Nursing forum (2017)
[96]
Evidence of selective reporting bias in hematology journals: A systematic review. — Wayant C, Scheckel C, Hicks C, Nissen T, Leduc L, Som M et al. PloS one (2017)
[97]
Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine. — Attai DJ, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim J et al. Seminars in hematology (2017)
[98]
Preanalytical influence of pneumatic tube delivery system on results of routine biochemistry and haematology analysis. — Petit M, Mine L, Pascreau T, Brouzes C, Majoux S, Borgel D et al. Annales de biologie clinique (2017)
[99]
How to build an allogeneic hematopoietic cell transplant unit in 2016: Proposal for a practical framework. — Crysandt M, Yakoub-Agha I, Reiß P, Theisen S, Silling G, Glatte P et al. Current research in translational medicine (2017)
[100]
Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance. — Collichio FA, Hess BJ, Muchmore EA, Duhigg L, Lipner RS, Haist S et al. Journal of cancer education : the official journal of the American Association for Cancer Education (2017)

Share:Twitter Reddit LinkedIn